Tag: #Global Trends

As part of a broader strategy to replenish its pipeline amid looming patent expirations, AbbVie has entered into an agreement... Read more

Deal Context: Expanding the Therapeutic Toolbox Following its promising ventures into the obesity market, New York-based Regeneron Pharmaceuticals has officially... Read more

Event Context: Eli Lilly’s Fourth Strategic Victory On April 13, 2026, Eli Lilly announced positive results from the Phase 3... Read more

The Incident: Allegations of Misleading Social Media Promotions The U.S. Food and Drug Administration (FDA) has issued an untitled letter... Read more

The pharmaceutical industry has entered a new chapter in the obesity treatment race as Eli Lilly officially launched Foundayo (orforglipron),... Read more

Pharmaceutical giant AbbVie has launched a legal challenge against the U.S. Department of Health and Human Services (HHS) and the... Read more

GC Biopharma has successfully developed and validated a proprietary assay designed to precisely measure impurities linked to thromboembolic risks. This... Read more

Halozyme Therapeutics Inc. has finalized a global exclusive collaboration and licensing agreement with Vertex Pharmaceuticals Incorporated. Under this pact, Vertex... Read more